Brief: Cipher Pharmaceuticals Q4 Net Income USD 13.311 Million
12/03/2026 21:00
Mar 12 (Reuters) - Cipher Pharmaceuticals Q4 EBITDA USD 6.528 million. Q4 adjusted EBITDA USD 6.968 million
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million